Evidence of
monosodium glutamate-induced adverse reactions: Double blind studies
As
evidence of MSG-induced brain lesions and endocrine disorders was confirmed by
neuroscientists, and the glutes could no longer claim
that monosodium glutamate did not cause brain damage and endocrine disorders in
laboratory animals, the glutes turned to production
of carefully designed human studies that limited the number of adverse reaction
reported, and would allow them to conclude that no relationship between MSG
ingestion and adverse reactions had been found.
Careful
review of the data presented in almost every published study will demonstrate
that a number of subjects experienced adverse reactions following ingestion of
monosodium glutamate test material. In
every case, those data were essentially ignored in data analyses, presentation
of results, and subsequent discussion.
Glutamate-Industry-Sponsored
Human Studies:
Subject Selection and Methodology Favoring
Production of Negative Results
(Compiled May 1, 2009)
|
AUTHORS |
FUNDING
SOURCES |
BIAS
TOWARD SELECTING SUBJECTS WHO MIGHT NOT BE SENSITIVE TO MONOSODIUM GLUTAMATE |
BIAS TOWARD REDUCING THE
LIKELIHOOD THAT SUBJECTS WOULD REACT TO MONOSODIUM GLUTAMATE TEST MATERIAL |
USE OF TOXIC OR
ALLERGENIC MATERIAL IN PLACEBOS |
USE
OF TOO FEW SUBJECTS |
FOCUS ON
VARIABLES IRRELEVANT TO PRODUCTION OF ADVERSE REACTIONS |
|
|
|
|
|
|
|
|
|
Altman DR, Fitzgerald T, Chiaramote LT. (1994) |
Allerx IGTC |
Stipend
given no other information provided |
Not
all reactions were recorded no other information |
3
different doses in a liquid vehicle IGTC placebos contained aspartame at
the time. |
|
|
|
Bazzano G, D=Elia JA, Olson RE.
(1970) |
Public Health Service |
Adult
males no other information provided |
Not
all reactions were recorded no other information |
Amino
acid formula with glutamate as a basic diet |
11 |
Neurologic function; Hepatic function;
Serum cholesterol; Weight. |
|
Fernstrom
JD, Cameron JL, Fernstrom M, McConaha C, Weltzin TE, Kaye WH. (1996) |
IGTC NIH |
Well
subjects Informed consent |
|
Beverage1 IGTC placebos contained aspartame at
the time. |
8 |
Plasma
glutamate; Change in plasma glutamate; Pituitary hormone secretion. |
|
Geha RS, Beiser
A, Ren C, Patterson R, Greenberger PA, Grammer LC, Ditto AM, Harris KE, Shaughnessy
MA, Yarnold PR, Corren J,
Saxon A. (2000) |
IGTC |
Stipend
given Informed consent |
Used
capsules Not
all reactions were recorded Observation time was inadequate |
Part
1:@Citrus-flavored
beverage.@2 Part
2: Capsules containing sucrose IGTC placebos contained aspartame at
the time the study was initiated. |
|
Reproducible
response;3 Pulse;
Blood pressure; Respiratory rate; Relative risk |
|
Germano P, Cohen SG,
Hahn B, Metcalfe DD. (1991) |
no information given |
13 non-asthmatic and 30 asthmatic
adults |
Not
all reactions were recorded Used capsules |
no
information provided IGTC placebos contained aspartame at
the time. |
13+30 1 |
|
|
Germano P, Cohen SG,
Hibbard V, Metcalfe DD. (1993) |
no information given |
21 adults with a history of asthma |
Not
all reactions were recorded Used capsules |
no
information provided IGTC placebos contained aspartame at
the time. |
21 10 |
|
|
Goldschmiedt M, Redfern JS, Feldman M. (1990) |
Ajinomoto; NIH; ILSI; VA. |
Well
subjects Informed consent |
|
180 mL worm
beef consomme soup supplied by Ajinomoto Co., Inc.
Tokyo |
17 15 |
Variables
were relevant to the study done, but irrelevant to adverse reactions to MSG |
|
Kenney
RA. (1979) Part 1. |
IGTC ( with thanks to NESTEC) |
Well
subjects Informed consent |
Test
material was given with carbohydrates Not
all reactions were recorded Observation time was inadequate |
Tomato
juice with common salt. |
51 16 |
|
|
Kenney RA. (1979) Part 2. |
IGTC |
Informed consent |
Observation time was inadequate |
Sucrose;
citric acid; trisodium-citrate; lemon flavor;
caramel color; naringin. |
57 16 |
|
|
Kenney, R.A. (1986) |
IGTC |
no information provided |
Not all reactions were recorded |
A...soft-drink
solution....@ IGTC placebos contained aspartame at
the time. |
6 |
Objective parameters (routine chemical
analyses) |
|
Kerr GR, Wu-Lee M, El-Lozy M, McGandy R, Stare F.J.
(1979) |
Ajinomoto USA |
Randomly drawn stratified random
sample |
Not
all reactions were recorded Observation time was inadequate |
Questionnaire
survey |
|
|
|
Morselli P, Garattini S. (1970) |
COFAG (IGTC Europe) |
Well subjects |
Test
material was given with carbohydrates Observation time was inadequate |
Beef broth (ingredients not specified)
followed by meat, vegetables, and fruit |
24 |
Blood pressure; Pulse; Respiration
rate |
|
Prawirohardjono W, Dwiprahasto I, Astuti I, Hadiwandowo S, Kristin E, Muhammad M, Kelly MF. (2000) |
IGTC |
Well
subjects Stipend
given Informed consent |
Small
amounts of test material were given with carbohydrates Used
capsules |
Lactose
in gelatin capsules |
52 |
Blood pressure; Pulse; Respiratory
rate |
|
Rosenblum L, Bradley J,
Coulston F. (1971) |
no information given |
Males
only Informed consent |
Not
all reactions were recorded Observation time was inadequate |
Diluted chicken stock or diluted
chicken stock with sodium (ingredients not specified) |
95 |
|
|
Schwartzstein RM, Kelleher
M, Weinberger WE, Weiss JW, Drazen JM. (1987) |
IGTC |
Asthmatics |
Not
all reactions were recorded Used
capsules Medication
not given for 12 hours prior to testing |
Gelatin capsule containing sodium
chloride |
12 |
|
|
Stegink LD, Filer J,
Baker GL, Bell EF. (1986) |
IGTC |
Informed
consent from parent no other information given |
Test
material was given with carbohydrates |
Beef consomme
supplied by Ajinomoto Co., Tokyo, Japan |
8 |
Plasma
glutamate; Plasma
aspartate |
|
Stevenson DD, Simon RA, Woessner KM. (1997) |
IGTC |
10
alleged CRS-asthmatics and 30 alleged non-CRS asthmatics Subjects eliminated |
Not
all reactions were recorded |
no
information given IGTC placebos contained aspartame at
the time. |
10+30 |
|
|
Tanphaichitr V, Srianujata S, Pothisiri P, Sammasut R, Kulapongese S. (1983) |
IGTC |
Well subjects |
Not
all reactions were recorded Test material was given with
carbohydrates |
Four full days= menus all
different, without added monosodium glutamate: this food being able to mask
the addition of monosodium glutamate |
50 |
Plasma
glutamate; Pleasantness
or unpleasantness of food |
|
Tanphaichitr V, Srianujata S, Leelahabul
P, Kulapongse
S, Patchimasiri S, Pothisiri
P. (1985) |
IGTC |
Well subjects |
Not all
reactions were recorded Test material
was given with carbohydrates |
A full day=s menu without
added monosodium glutamate |
12 |
|
|
Tarasoff L,
Kelly MF. (1993) |
IGTC |
Well subjects Stipend given Informed
consent |
Used capsules Test material
was given with carbohydrates Not all
reactions were recorded Observation
time was inadequate |
Both beverage
and capsules: Beverage
specified as containing aspartame;4 prepared from powders supplied
by the IGTC Placebos in
gelatin capsules |
|
After-taste;
Intensity |
|
Wilkin JK
(1986) |
VA |
Well subjects |
Not all
reactions were recorded |
no placebo |
6 |
|
|
Woessner KM, Simon RA, Stevenson DD (1999) |
IGTC; Scripps
Clinic, Green Hospital, &
Research Institute |
30
asthmatics with alleged CRS asthma and
70 without Informed
consent Subjects
eliminated |
Not all
reactions were recorded Test material
was given with carbohydrates Continued
medications |
5 gelatin
capsules containing sucrose IGTC placebos
contained aspartame at the time. |
30+70 30 |
|
|
Yang WH, Drouin MA, Herbert M, Mao Y. (1997) |
IGTC |
Well subjects
(except subjects with symptoms of CRS were accepted) Stipend given Informed
consent |
Not all
reactions were recorded Two or more
reactions were required to be counted as a reaction Observation
time was inadequate |
Strongly citrus
tasting beverage containing sucrose supplied by the IGTC IGTC placebos
contained aspartame at the time. |
61 36 |
|
|
Zanda G, Franciosi P, Tognoin G, Risso M, Standen, SM, Morselli PL, Garattini S.
(1973) |
no information
given |
Well subjects |
Not all
reactions were recorded Observation
time was inadequate Small amounts
of test material were given with carbohydrates |
Beef bouillon
(ingredients not specified) |
72 |
Blood
pressure; Pulse rate |
LEGEND
FUNDING
SOURCES:
COFAG: IGTC Europe
IGTC: International Glutamate
Technical Committee (includes manufacturers and users of monosodium glutamate)
ILSI: International Life Sciences
Institute (often under contract to the glutamate industry)
IMC: International Minerals and
Chemical Corporation
NIH: National Institutes of
Health
VA: Veterans Administration
BIAS
IN SELECTING SUBJECTS
(Not all people are sensitive to monosodium glutamate at levels ordinarily
found in food.)
CRS: Chinese Restaurant
Syndrome: a limited number of mild and transitory reactions reported in
1968 as occurring between10 minutes and 2 hours after the start of a meal and
lasting less than four hours.
INFORMED CONSENT, while ethically
appropriate, and required of all experiments using human subjects, biases these
studies.
MALES have been reputed to be
less sensitive to MSG than females
STIPENDS were offered to subjects
who claimed to be sensitive to MSG
SUBJECTS were ELIMINATED prior to the study for responding to
placebos that were going to be used in the study.
WELL SUBJECTS would be persons
who had never experienced any of the reactions alleged to be attributable to
use of monosodium glutamate – examples of those reactions being irritable
bowel, migraine headache, asthma, skin rash, heart irregularities, mood swings,
and depression.
BIAS
TOWARD REDUCING THE LIKELIHOOD THAT SUBJECTS WOULD REACT TO MONOSODIUM
GLUTAMATE TEST MATERIAL
CAPSULES guarantee slow release
and, therefore, less effect from the material they contain
TEST MATERIAL GIVEN WITH
CARBOHYDRATES interferes with the uptake of the test material
PLACEBOS
It would appear that in most, if
not all, glutamate-industry-sponsored studies, both test and placebo material were supplied by the IGTC. According to a 1991 letter from IGTC chairman
Andrew G. Ebert to LSRO-FASEB and the FDA, a Abeverage mix designed to mask the
taste of [monosodium glutamate]@, was modified in 1978 to replace
the [former use of] surcose with the low calorie
sweetener Aspartame. Prior to the time
that Northwestern University was alerted by the Truth in Labeling Campaign to
the fact that aspartame was being used in placebo material being used in an IGTC-sponsored
study being carried out by Geha et al. at Northwestern, Harvard, and UCLA, the
use of aspartame in placebos was not acknowledged in research reports.
BEVERAGE(1): Citric acid, trisodium citrate, lemon flavoring, caramel coloring,
naringenin-7-rhamnosidio-glycoside (grapefruit bitter principle), sodium
saccharin; prepared by Ajinomoto
CITRUS-FLAVORED BEVERAGE(2): Sodium citrate, citric acid, saccharin, citrus
flavor, and naringin were cited as ingredients. Aspartame was used (but not named) with the
other ingredients prior to objections filed with Northwestern University by the
Truth in Labeling Campaign.
BEVERAGE(4): Sodium citrate dihydrate,
citric acid monohydrate, potassium chloride, naringin,
grapefruit flavor, caramel, and aspartame.
IRRELEVANT
VARIABLES
REPRODUCIBLE RESPONSE: (3)
Repetition of the same two or more responses to monosodium glutamate on two
occasions, and no response to the Aplacebo@
(which contained aspartame).
REFERENCES
Altman
DR, Fitzgerald T, Chiaramonte LT. Double‑blind
placebo‑controlled challenge (DBPCC) of persons
reporting adverse reactions to monosodium
glutamate (MSG). J Allergy Clin Immunol. 1994;93:303
(Abstract 844).
Bazzano G, D=Elia JA, Olson RE. Monosodium
glutamate: feeding of large amounts in man and gerbils. Science.
1970;169:1208‑1209.
Fernstrom
JD, Cameron JL, Fernstrom MH, McConaha C, Weltzin TE, Kaye WH. Short‑term
neuroendocrine
effects of a large, oral dose of
monosodium glutamate in fasting male subjects. J Clin Endocrinol Metab. 1996;81:184‑191.
Geha R, Beiser
A, Ren C, et al. Multicenter multiphase double blind
placebo controlled study to evaluate alleged reactions to monosodium glutamate
(MSG). J Allergy Clin Immunol. 2000;106:973-980.
Germano P, Cohen SG, Hahn B, Metcalfe
DD. An evaluation of clinical reactions to monosodium
glutamate (MSG) in asthmatics using a blinded, placebo‑controlled
challenge. J Allergy Clin
Immunol. 1991;87:
177 (Abstract 155).
Germano P, Cohen SG, Hibbard V, Metcalfe
DD. Assessment of bronchial hyperactivity by methacholine
challenge (MTC) in asthmatics before and after
monosodium glutamate (MSG) administration. J
Allergy Clin Immunol.
1993;91:340 (Abstract 798).
Goldschmiedt M, Redfern
JS, Feldman M. Food coloring and monosodium glutamate: effects on the cephalic
phase of gastric acid secretion and gastrin release
in humans. Am J Clin Nutr. 1990;51:794‑797.
Kenney RA. Placebo‑controlled
studies of human reaction to oral monosodium L‑glutamate.
In Filer LJ Jr, Garattini
S. Kare MR, Reynolds WA, Wurtman RJ, eds. Glutamic
acid: advances in biochemistry and physiology. New York: Raven;
1979:363-373.
Kenney RA. The Chinese restaurant
syndrome: an anecdote revisited. Food Chem Toxicol.
1986;24:351-354.
Kerr GR, Wu‑Lee
M, El‑Lozy M, McGandy
R, Stare FJ. Prevalence of the "Chinese restaurant
syndrome." J Am Diet Assoc. 1979; 75:29‑33.
Morselli P, Garattini S. Monosodium‑glutamate
and the Chinese restaurant syndrome. Nature. 1970;227:611‑612.
Prawirohardjono W, Dwiprahasto I, Astuti I, et al.
The administration to Indonesians of monosodium
L-glutamate in Indonesian foods; an assessment of adverse reactions in a
randomized double-blind, crossover, placebo-controlled study. Nutr 2000; 130: 1074S-1076S.
Rosenblum L, Bradley J, Coulston F. Single and double blind studies with oral
monosodium glutamate in man. Toxicol Appl Pharmacol
1971; 18:367-373.
Schwartzstein RM, Kelleher
M, Weinberger WE, Weiss JW, Drazen JM. Airway effect
of monosodium glutamate in subjects with chronic stable asthma. J Asthma. 1987;24:167-172
Stegink LD, Filer J,
Baker GL, Bell EF.
Plasma glutamate concentrations in 1-year-old infants and
adults ingesting monosodium L-glutamate in consomme.
Pediatr Res. 1986;20:53-58.
Stevenson DD, Simon RA, Woessner KM. The role of monosodium L‑glutamate
(MSG) in asthma: does it exist? J Allergy Clin Immunol. 1997;99:S411 (Abstract 1670).
Tanphaichitr V, Srianujata
S, Pothisiri P, Sammasut
R, Kulapongese
S. Postprandial responses to Thai foods with and without added monosodium
L-glutamate. Nutr
Rep Int. 1983;28:783-792.
Tanphaichitr V, Srianujata
S, Leelahabul P,
Kulapongse S, Patchimasiri
S, Pothisiri P. Effect of monosodium L-glutamate in
take on protein-calorie status in healthy Thai adults. Nutr
Rep Int. 1985;32:1073-1080.
Tarasoff L, Kelly MF. Monosodium L‑glutamate: a double‑blind
study and review. Food Chem
Toxic. 1993;31:1019‑1035.
Wilkin JK. Does monosodium
glutamate cause flushing (or merely Aglutamania@)?
J Am Acad Dermatol. 1986;15:225-230.
Woessner KM, Simon RA, Stevenson DD. Monosodium
glutamate sensitivity in asthma. J Allergy Clin Immunol. 1999; 104: 305-310.
Yang WH, Drouin MA, Herbert M, Mao Y. The monosodium glutamate symptom
complex: assessment in a double‑blind, placebo‑controlled, randomized study. J Allergy Clin Immunol.
1997; 99:757‑762.
Zanda G, Franciosi
P, Tognoin G, et al. A double blind
study on the effects of monosodium glutamate in man. Biomedicine.
1973;19:202-204.